Preeclampsia and aspirin
Preeclampsia (PE) is a multisystem disorder that is an important cause of maternal and perinatal deaths. Currently, delivery is the only final treatment for PE. This practice is usually accompanied by premature birth, which inevitably increases neonatal morbidities. Aspirin is a non-selective non-st...
Saved in:
Main Authors: | Tae Gyu Ahn (Author), Jong Yun Hwang (Author) |
---|---|
Format: | Book |
Published: |
Korean Society of Obstetrics and Gynecology,
2023-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Missed opportunities in aspirin prescribing for preeclampsia prevention
by: Noreen Singh, et al.
Published: (2023) -
Screening for Preeclampsia in the First Trimester and Aspirin Prophylaxis: Our First Year
by: Inês Lourenço, et al.
Published: (2020) -
Aspirin for preeclampsia prevention in low- and middle-income countries: mind the gaps
by: Ellen Kupka, MD, et al.
Published: (2024) -
The preventive effect of low-dose aspirin in a PPAR-γ antagonist treated mouse model of preeclampsia
by: Yongbing Guo, et al.
Published: (2022) -
PREGNANCY AND DELIVERY IN WOMEN WITH A HISTORY OF PREECLAMPSIA HYPERHOMOCYSTEINEMIA TREATED WITH BEMIPARIN IN COMBINATION WITH LOW-DOSE ASPIRIN
by: L. O. Buzyan, et al.
Published: (2016)